about
Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous AustraliansThe POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in AustraliaThe impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.An expert panel assessment of comprehensive medication reviews for clients of community mental health teams.Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study.Interrater agreement and interrater reliability: key concepts, approaches, and applications.A retrospective study of psychotropic drug use among individuals with mental illness issued a community treatment order.Factors associated with antipsychotic polypharmacy and high-dose antipsychotics among individuals receiving compulsory treatment in the community.The extent and correlates of community-based pharmaceutical opioid utilisation in Australia.An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia.A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence.Imprisonment of opioid-dependent people in New South Wales, Australia, 2000–2012: a retrospective linkage study.A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.Effect of comorbidity on the risk of death associated with antipsychotic use among community-dwelling older adults.A synthesis of oral morphine equivalents (OME) for opioid utilisation studies.Engagement with the criminal justice system among opioid-dependent people: a retrospective cohort study.A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women.To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?Psychotropic drug-regimen changes between community treatment orders.The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids.Prevalence and incidence of prescription opioid analgesic use in AustraliaA population-based study of transdermal fentanyl initiation in Australian clinical practicePsychiatric Drug Use Among Patients of a Community Mental Health ServiceExtra-medical use of antipsychotics: what can be learnt from experiences with other prescription medicines?Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer painProtocol for the Data-Linkage Alcohol Cohort Study (DACS): investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative dataPatterns and correlates of prescribed and non-prescribed pregabalin use among a sample of people who inject drugs in Australia
P50
Q34207684-F92DA7B5-D785-4957-9321-D3AA7507B25DQ35046861-5753F819-DB55-46AF-A1EC-23350EC15A10Q35115444-B015D340-2B6C-45A4-8D59-3645E199938BQ37614242-EEC88277-52A4-411A-819B-B6770A199B47Q37704453-D2AF9F41-1A29-4B0F-9B4F-B868C0104709Q38018438-1AC83ACD-4EE1-4F57-9411-689BF933EEE3Q38174188-964E1F02-B4CE-466C-9E5A-8331E2E148B3Q38203365-13EBA5B9-2AC2-4A35-8A40-4DB141AD4BF6Q40093401-5589008F-357D-4AE5-A0E5-F6F2910286C7Q40185150-FFBBF7F0-EE12-4D6E-AE3E-3A4DD69783CEQ40694972-CCACD633-B29A-4D7E-A743-731660A018F9Q41072782-CF99AA40-0D45-4B39-B46A-33D109E0CCA7Q41681373-AF15497F-D042-472A-BE94-194D49FB2153Q43889043-33B18606-90E8-4AB4-8E08-B53B9FF9AB52Q44334284-F87957B9-FA53-45CF-A6EB-C8B8C56B5F11Q44340732-27777218-055A-4E02-B169-03700190D9D9Q44344923-8CB212ED-FB0C-455F-B333-C7A671D511A5Q44349921-633F2B27-DE08-4173-A2BC-7C25C9372A8DQ44804806-27BE7604-F887-4DC3-A6F9-AB0AE95C0A11Q44993116-D244767B-656A-40EF-9220-72E19D42A3DCQ58586567-67DFF6DE-80E3-4A86-B86A-9EA58AD9F8FCQ58614001-A34C63BA-66CF-4630-8BCC-A25E63243893Q59555712-3B4D63BE-80FF-417B-AB39-E4EAE65EBF50Q90112377-B8A36B7E-AC97-4F05-88A5-2173A8FF197DQ92004608-B2D79C96-CE4C-4966-920F-5EEECB5B1F27Q92430523-A1D0A1F5-C1A9-43DB-B8CB-D4846E1D65F3Q96585355-46869F41-23C1-4054-8C56-9EC69437E498
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Natasa Gisev
@ast
Natasa Gisev
@en
Natasa Gisev
@es
Natasa Gisev
@nl
Natasa Gisev
@sl
type
label
Natasa Gisev
@ast
Natasa Gisev
@en
Natasa Gisev
@es
Natasa Gisev
@nl
Natasa Gisev
@sl
altLabel
Gisev N
@en
prefLabel
Natasa Gisev
@ast
Natasa Gisev
@en
Natasa Gisev
@es
Natasa Gisev
@nl
Natasa Gisev
@sl
P1053
M-6945-2016
P106
P21
P31
P3829
P496
0000-0003-0452-8470